178 related articles for article (PubMed ID: 21607568)
21. Antibacterial effects of blackberry extract target periodontopathogens.
González OA; Escamilla C; Danaher RJ; Dai J; Ebersole JL; Mumper RJ; Miller CS
J Periodontal Res; 2013 Feb; 48(1):80-6. PubMed ID: 22812456
[TBL] [Abstract][Full Text] [Related]
22. Selective inhibition of Porphyromonas gingivalis growth by a factor Xa inhibitor, DX-9065a.
Matsushita K; Imamura T; Tancharoen S; Tatsuyama S; Tomikawa M; Travis J; Potempa J; Torii M; Maruyama I
J Periodontal Res; 2006 Jun; 41(3):171-6. PubMed ID: 16677284
[TBL] [Abstract][Full Text] [Related]
23. [Antibacterial activity of new-quinolone and macrolide antibiotics against oral bacteria].
Eguchi T; Shimizu Y; Furuhata K; Fukuyama M
Kansenshogaku Zasshi; 2002 Nov; 76(11):939-45. PubMed ID: 12508477
[TBL] [Abstract][Full Text] [Related]
24. Antibacterial effect of N-acetylcysteine and taurolidine on planktonic and biofilm forms of Enterococcus faecalis.
Ulusoy AT; Kalyoncuoğlu E; Reis A; Cehreli ZC
Dent Traumatol; 2016 Jun; 32(3):212-8. PubMed ID: 26515652
[TBL] [Abstract][Full Text] [Related]
25.
Jayanti I; Jalaluddin M; Avijeeta A; Ramanna PK; Rai PM; Nair RA
J Contemp Dent Pract; 2018 Apr; 19(4):415-419. PubMed ID: 29728546
[No Abstract] [Full Text] [Related]
26. Effects of taurolidine and chlorhexidine on SaOS-2 cells and human gingival fibroblasts grown on implant surfaces.
John G; Becker J; Schwarz F
Int J Oral Maxillofac Implants; 2014; 29(3):728-34. PubMed ID: 24818214
[TBL] [Abstract][Full Text] [Related]
27. Initial effect of controlled release chlorhexidine on subgingival microorganisms.
Daneshmand N; Jorgensen MG; Nowzari H; Morrison JL; Slots J
J Periodontal Res; 2002 Oct; 37(5):375-9. PubMed ID: 12366861
[TBL] [Abstract][Full Text] [Related]
28. Taurolidine: in vitro activity against multiple-antibiotic-resistant, nosocomially significant clinical isolates of Staphylococcus aureus, Enterococcus faecium, and diverse Enterobacteriaceae.
Traub WH; Leonhard B; Bauer D
Chemotherapy; 1993; 39(5):322-30. PubMed ID: 8370323
[TBL] [Abstract][Full Text] [Related]
29. Killing activity of LFchimera on periodontopathic bacteria and multispecies oral biofilm formation in vitro.
Ruangcharoen S; Suwannarong W; Lachica MRCT; Bolscher JGM; Nazmi K; Khunkitti W; Taweechaisupapong S
World J Microbiol Biotechnol; 2017 Aug; 33(9):167. PubMed ID: 28823045
[TBL] [Abstract][Full Text] [Related]
30. Influence of a triclosan toothpaste on periodontopathic bacteria and periodontitis progression in cardiovascular patients: a randomized controlled trial.
Seymour GJ; Palmer JE; Leishman SJ; Do HL; Westerman B; Carle AD; Faddy MJ; West MJ; Cullinan MP
J Periodontal Res; 2017 Feb; 52(1):61-73. PubMed ID: 26932733
[TBL] [Abstract][Full Text] [Related]
31. The in Vitro Antimicrobial Efficacy of PDT against Periodontopathogenic Bacteria.
Haag PA; Steiger-Ronay V; Schmidlin PR
Int J Mol Sci; 2015 Nov; 16(11):27327-38. PubMed ID: 26580607
[TBL] [Abstract][Full Text] [Related]
32. Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid), taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of biofilm-producing staphylococci from central venous catheters.
Luther MK; Mermel LA; LaPlante KL
J Antimicrob Chemother; 2014 Dec; 69(12):3263-7. PubMed ID: 25096074
[TBL] [Abstract][Full Text] [Related]
33. Quantitative real-time PCR combined with propidium monoazide for the selective quantification of viable periodontal pathogens in an in vitro subgingival biofilm model.
Sánchez MC; Marín MJ; Figuero E; Llama-Palacios A; León R; Blanc V; Herrera D; Sanz M
J Periodontal Res; 2014 Feb; 49(1):20-8. PubMed ID: 23581569
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial activity of silver nitrate against periodontal pathogens.
Spacciapoli P; Buxton D; Rothstein D; Friden P
J Periodontal Res; 2001 Apr; 36(2):108-13. PubMed ID: 11327077
[TBL] [Abstract][Full Text] [Related]
35. Effects of sub-minimal inhibitory concentrations of antibiotics on the morphology and surface hydrophobicity of periodontopathic anaerobes.
Lee SY; Lee SY
Anaerobe; 2019 Feb; 55():107-111. PubMed ID: 30423437
[TBL] [Abstract][Full Text] [Related]
36. In vitro antimicrobial susceptibility of periodontopathic Actinobacillus actinomycetemcomitans to roxithromycin and erythromycin.
Piccolomini R; Di Bonaventura G; Catamo G; Picciani C; Paolantonio M
Oral Microbiol Immunol; 1997 Dec; 12(6):366-71. PubMed ID: 9573812
[TBL] [Abstract][Full Text] [Related]
37. Taurolidine inhibits tumor cell growth in vitro and in vivo.
McCourt M; Wang JH; Sookhai S; Redmond HP
Ann Surg Oncol; 2000 Oct; 7(9):685-91. PubMed ID: 11034247
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the Efficacy of Guava Extract as an Antimicrobial Agent on Periodontal Pathogens.
Shetty YS; Shankarapillai R; Vivekanandan G; Shetty RM; Reddy CS; Reddy H; Mangalekar SB
J Contemp Dent Pract; 2018 Jun; 19(6):690-697. PubMed ID: 29959298
[TBL] [Abstract][Full Text] [Related]
39. Taurolidine as an effective and biocompatible additive for plaque-removing techniques on implant surfaces.
John G; Schwarz F; Becker J
Clin Oral Investig; 2015 Jun; 19(5):1069-77. PubMed ID: 25346373
[TBL] [Abstract][Full Text] [Related]
40. Antibacterial efficacy of exogenous nitric oxide on periodontal pathogens.
Backlund CJ; Sergesketter AR; Offenbacher S; Schoenfisch MH
J Dent Res; 2014 Nov; 93(11):1089-94. PubMed ID: 25139363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
